Free Trial

Anteris Technologies Global (AVR) Competitors

Anteris Technologies Global logo
$4.15 +0.33 (+8.64%)
As of 08/22/2025 04:00 PM Eastern

AVR vs. AVNS, ZIMV, KIDS, TMCI, SMLR, CBLL, DCTH, BFLY, SNWV, and RXST

Should you be buying Anteris Technologies Global stock or one of its competitors? The main competitors of Anteris Technologies Global include Avanos Medical (AVNS), ZimVie (ZIMV), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), CeriBell (CBLL), Delcath Systems (DCTH), Butterfly Network (BFLY), Sanuwave Health (SNWV), and RxSight (RXST). These companies are all part of the "medical equipment" industry.

Anteris Technologies Global vs. Its Competitors

Anteris Technologies Global (NASDAQ:AVR) and AVANOS MEDICAL (NYSE:AVNS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations.

Anteris Technologies Global presently has a consensus target price of $16.50, indicating a potential upside of 297.59%. Given Anteris Technologies Global's stronger consensus rating and higher possible upside, analysts plainly believe Anteris Technologies Global is more favorable than AVANOS MEDICAL.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anteris Technologies Global
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
AVANOS MEDICAL
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Anteris Technologies Global has higher earnings, but lower revenue than AVANOS MEDICAL.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anteris Technologies Global$2.70M55.43-$76.29MN/AN/A
AVANOS MEDICAL$687.80M0.79-$392.10M-$10.07-1.16

Anteris Technologies Global has a net margin of 0.00% compared to AVANOS MEDICAL's net margin of -66.89%. AVANOS MEDICAL's return on equity of 6.16% beat Anteris Technologies Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Anteris Technologies GlobalN/A N/A N/A
AVANOS MEDICAL -66.89%6.16%4.57%

In the previous week, AVANOS MEDICAL had 1 more articles in the media than Anteris Technologies Global. MarketBeat recorded 1 mentions for AVANOS MEDICAL and 0 mentions for Anteris Technologies Global. AVANOS MEDICAL's average media sentiment score of 1.78 beat Anteris Technologies Global's score of 0.00 indicating that AVANOS MEDICAL is being referred to more favorably in the news media.

Company Overall Sentiment
Anteris Technologies Global Neutral
AVANOS MEDICAL Very Positive

95.2% of AVANOS MEDICAL shares are owned by institutional investors. 2.6% of AVANOS MEDICAL shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

AVANOS MEDICAL beats Anteris Technologies Global on 7 of the 13 factors compared between the two stocks.

Get Anteris Technologies Global News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVR vs. The Competition

MetricAnteris Technologies GlobalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$137.76M$6.88B$5.76B$9.58B
Dividend YieldN/A1.31%4.41%4.10%
P/E RatioN/A27.4531.1026.05
Price / Sales55.4375.30435.79105.95
Price / CashN/A21.3437.7358.48
Price / Book6.196.889.536.61
Net Income-$76.29M$176.42M$3.26B$265.56M
7 Day Performance2.72%1.45%2.09%1.97%
1 Month Performance25.76%-2.71%2.81%-0.36%
1 Year PerformanceN/A9.40%30.56%19.03%

Anteris Technologies Global Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVR
Anteris Technologies Global
N/A$4.15
+8.6%
$16.50
+297.6%
N/A$137.76M$2.70M0.00138
AVNS
Avanos Medical
3.2926 of 5 stars
$11.68
+4.6%
N/A-49.6%$541.33M$692.50M-1.162,227Short Interest ↑
ZIMV
ZimVie
0.7222 of 5 stars
$19.00
+0.3%
$17.75
-6.6%
+11.2%$535.66M$449.75M-27.141,770Positive News
Short Interest ↑
KIDS
OrthoPediatrics
3.955 of 5 stars
$20.14
+5.2%
$34.14
+69.5%
-32.9%$501.73M$220.73M-11.25200
TMCI
Treace Medical Concepts
2.6439 of 5 stars
$7.68
+5.7%
$9.83
+28.1%
+24.2%$485.78M$209.36M-9.73250Positive News
SMLR
Semler Scientific
3.6261 of 5 stars
$31.65
+5.1%
$81.75
+158.3%
+11.0%$468.09M$56.29M13.01120
CBLL
CeriBell
2.3845 of 5 stars
$12.04
+3.0%
$32.14
+167.1%
N/A$441.22M$77.42M-4.02N/APositive News
DCTH
Delcath Systems
2.6673 of 5 stars
$11.11
+6.7%
$24.50
+120.5%
+41.3%$388.59M$37.21M222.1860Short Interest ↑
BFLY
Butterfly Network
2.9845 of 5 stars
$1.53
+9.7%
$3.00
+96.7%
+68.9%$383.90M$82.06M-5.45460
SNWV
Sanuwave Health
1.4963 of 5 stars
$44.71
+8.4%
$55.00
+23.0%
N/A$383.17M$32.63M-5.4240Positive News
Analyst Forecast
RXST
RxSight
1.0235 of 5 stars
$9.29
+6.4%
$10.00
+7.7%
-82.9%$379.12M$139.93M-11.58220Trending News
Short Interest ↑

Related Companies and Tools


This page (NASDAQ:AVR) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners